Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Neuroblastoma 15Central Nervous System Neoplasms 12Testicular Neoplasms 9Testicular Germ Cell Tumor 8Teratoma 6Sarcoma 6Ovarian Neoplasms 6Carcinoma, Renal Cell 5Seminoma 4Neuroectodermal Tumors, Primitive, Peripheral 4Medulloblastoma 4Endodermal Sinus Tumor 4Astrocytoma 4Wilms Tumor 3Rhabdoid Tumor 3Retinoblastoma 3Osteosarcoma 3Optic Nerve Glioma 3Neoplasms 3Kidney Neoplasms 3Carcinoma, Embryonal 3Brain Neoplasms 3Spinal Cord Neoplasms 2Rhabdomyosarcoma 2Liver Neoplasms 2Hepatoblastoma 2Familial ependymoma 2Chondrosarcoma 2Uveal Melanoma 1Urinary Bladder Neoplasms 1

Interventions

Filgrastim 2Docetaxel 2etoposide phosphate 1entinostat 1Thalidomide 1SUB1 protein, human 1Peripheral Blood Stem Cell Transplantation 1Ifosfamide 1Gemcitabine 1Etoposide 1Carboplatin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
AIDS-related Kaposi sarcoma × Ifosfamide × CNS × Clear all
NCT00003657 2017-01-20

High-dose ICE With Amifostine

Dana-Farber Cancer Institute

Phase 2 Completed
24 enrolled
CNSGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Testicular Germ Cell Tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Unknown Primary, Ovarian Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡